Curaleaf Holdings, Inc.
TSX:CURA.TO · Toronto Stock Exchange
-$0.12 today
Vol 0.17M · Avg 0.29M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
TSX:CURA.TO · Revenue to Net Income
Key Ratios
Analysis
$1.3B of revenue converted into -$114.1M of net income for the selected period. Gross margin is 43.6% and net margin is -8.7%, showing how much revenue survives after costs and taxes. EPS is $-0.44, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B -3.9% | $1.3B -0.3% | $1.3B +0.8% | $1.3B +10.5% | $1.2B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $792.1M +12.6% | $703.6M -3.9% | $732.2M -3.3% | $757.3M +45.1% | $522.1M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $498.2M -22.1% | $639.2M +4.0% | $614.4M +6.1% | $579.0M -15.8% | $687.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 38.6% -9.0pp | 47.6% +2.0pp | 45.6% +2.3pp | 43.3% -13.5pp | 56.8% | 9.8% | 28.9% | 38.3% |
| Research & Development | $819.1K | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $458.1M +2.4% | $447.2M +2.9% | $434.8M -8.6% | $475.6M +14.4% | $415.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $472.3M -23.7% | $619.1M +8.3% | $571.6M -3.4% | $591.4M +15.5% | $512.0M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $143.9M -42.5% | $250.2M +27.7% | $195.9M +23.1% | $159.1M +20.2% | $132.4M | $374.2M | $1.2B | $631.8M |
| EBITDA | $169.8M -27.2% | $233.1M -2.4% | $238.8M +8.1% | $221.0M -20.8% | $279.0M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 13.2% -4.2pp | 17.4% -0.4pp | 17.7% +1.2pp | 16.5% -6.5pp | 23.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $25.9M +28.2% | $20.2M -52.9% | $42.9M +518.5% | -$10.2M -105.8% | $175.6M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 2.0% +0.5pp | 1.5% -1.7pp | 3.2% +4.0pp | -0.8% -15.3pp | 14.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $674.6K -13.1% | $776.0K +3273.9% | $23.0K -83.1% | $136.0K -78.4% | $629.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $102.6M +2.0% | $100.6M +0.2% | $100.4M +13.0% | $88.8M +13.2% | $78.5M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$105.5M +23.5% | -$137.8M +17.6% | -$167.2M +21.9% | -$214.1M -77.3% | -$120.8M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$79.6M +32.3% | -$117.6M +5.4% | -$124.4M +45.1% | -$226.4M -449.4% | $64.8M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -6.2% +2.6pp | -8.8% +0.5pp | -9.2% +7.7pp | -16.9% -22.3pp | 5.4% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $125.9M +27.7% | $98.6M -14.0% | $114.6M -23.9% | $150.5M -13.5% | $173.9M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$235.1M -9.1% | -$215.4M +23.4% | -$281.2M +25.4% | -$376.9M -245.4% | -$109.1M | $4.9B | $4.8B | $4.7B |
| Net Margin | -18.2% -2.2pp | -16.0% +4.8pp | -20.9% +7.3pp | -28.2% -19.2pp | -9.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 -6.9% | -$1 +9.4% | -$1 +39.6% | -$2 -231.3% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 -6.9% | -$1 +25.6% | -$1 +26.4% | -$2 -231.3% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $254.0M +2.6% | $247.5M +2.5% | $241.4M +1.8% | $237.1M +1.8% | $232.9M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $254.0M +2.6% | $247.5M +2.5% | $241.4M +1.8% | $237.1M +1.8% | $232.9M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Trulieve Cannabis Corp.
TRUL.CN
$2.74B
Green Thumb Industries Inc.
GTII.CN
$2.45B
Bausch Health Companies Inc.
TSX:BHC.TO
$2.42B
Cronos Group Inc.
TSX:CRON.TO
$1.40B
Tilray Brands, Inc.
TSX:TLRY.TO
$786.99M
Verano Holdings Corp.
VRNO.NE
$580.26M
Cresco Labs Inc.
CL.CN
$396.73M
HLS Therapeutics Inc.
TSX:HLS.TO
$131.35M
iAnthus Capital Holdings, Inc.
IAN.CN
$69.73M
Greenway Greenhouse Cannabis Corporation
GWAY.CN
$19.26M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does CURA.TO generate?
Curaleaf Holdings, Inc. (CURA.TO) reported $1.29B of revenue in fiscal 2025.
Is CURA.TO profitable?
Curaleaf Holdings, Inc. (CURA.TO) reported -$235,115,000.00 of net income, with a net margin of -18.2%.
Explore More
Continue the stock analysis
Jump to another research area for this company.